ArticleJournal of inflammation research2024

FSCN1 is a Potential Therapeutic Target for Atherosclerosis Revealed by Single-Cell and Bulk RNA Sequencing.

Lili Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.